Vicept Therapeutics
Signal active
Organization
Contact Information
Overview
Vicept (Vicept Therapeutics, Inc.), based in Malvern, Pennsylvania, is a privately held specialty biopharmaceutical company founded in August, 2009 with a mission to develop the first effective topically applied-therapy directed toward the erythema (skin redness) of rosacea and other dermatologic disorders characterized by redness and or 'flushing' of the skin.
About
Industries
Biotechnology, Medical, Biopharma
Founded
2009
Employees
10001+
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Vicept Therapeutics headquartered in United States, North America, operates in the Biotechnology, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $384.0M in funding across 24 round(s). With a team of 10001+ employees, Vicept Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Vicept Therapeutics, raised $16.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
4
Lead Investors
0
Total Funding Amount
$16.0M
Details
1
Vicept Therapeutics has raised a total of $16.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2010 | Early Stage Venture | 16.0M |
Investors
Vicept Therapeutics is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| F-Prime Capital | - | FUNDING ROUND - F-Prime Capital | 16.0M |
| Albert Cha | - | FUNDING ROUND - Albert Cha | 16.0M |
| Vicept Therapeutics | - | FUNDING ROUND - Vicept Therapeutics | 16.0M |
| Vivo Capital | - | FUNDING ROUND - Vivo Capital | 16.0M |
Recent Activity
There is no recent news or activity for this profile.